Back to top

Tale of the Tape

Zacks Equity Research

Surgery Partners (SGRY) is Oversold: Can It Recover?
November 10, 2016

SGRY

Trades from $3

Surgery Partners, Inc. (SGRY - Free Report) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at SGRY given that, according to its RSI reading of 27.16, it is now in oversold territory.

What is RSI?

RSI stands for ‘Relative Strength Index’ and it is a popular indicator used by technically focused investors. It compares the average of gains in days that closed up to the average of losses in days that closed down; readings above 70 suggest an asset is overbought, while an RSI below 30 suggests undervalued conditions are present.

Other Factors

Yet, SGRY’s low RSI value isn’t the only reason to have some optimism over a coming turnaround, as there has been plenty of positive earnings estimate revision activity as of late. This is especially true when investors take a deep dive into some of these estimate revision stats and recent changes to Surgery Partners' earnings consensus.

Over the past two months, investors have seen 1 earnings estimate revisions move higher, compared with just none lower, at least when looking at the key current year time frame. And the consensus estimate for SGRY has also been on an upward trend over the past 60 days, as estimates have risen from $0.60/share two months ago to just $0.61/share right now. 

If this wasn’t enough, Surgery Partners also has a Zacks Rank #2 (Buy)which puts it into rare company among its peers. So, given all of these factors, investors may want to consider getting in on this stock now (or holding on), as there are some favorable trends that could bubble up for this stock before long You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Best Place to Start Your Stock Search

Today, you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buy" stocks – absolutely free of charge. Since 1988, Zacks Rank #1 stocks have nearly tripled the market, with average gains of +26% per year. Plus, you can access the list of portfolio-killing Zacks Rank #5 "Strong Sells" and other private research. See these stocks free >>


In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

SURGERY PARTNRS (SGRY) - free report >>